Insulin-like growth factor 1 protects human neuroblastoma cells SH-EP1 against MPP+-induced apoptosis by AKT/GSK-3β/JNK signaling

Apoptosis

Volumn 15, Issue 12, 2010, Pages 1470-1479

  Wang, Lei ^a   Yang, Hai Jie ^a   Xia, Yin Yan ^a   Feng, Zhi Wei ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

AKT; Apoptosis; GSK 3 ; IGF 1; JNK; MPP+; SH EP1

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; JANUS KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROTOXICITY; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

1-METHYL-4-PHENYLPYRIDINIUM; APOPTOSIS; CELL LINE, TUMOR; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEUROBLASTOMA; NEURONS; ONCOGENE PROTEIN V-AKT; PARKINSON DISEASE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 78649941632     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-010-0547-z     Document Type: Article

References (65)

1. O Eberhardt JB Schulz 2003 Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease Toxicol Lett 139 135 151 1:CAS:528:DC%2BD3sXhvFeqsrc%3D 10.1016/S0378-4274(02)00428-9 12628749 (Pubitemid 36298972)
2. W Dauer S Przedborski 2003 Parkinson's disease: mechanisms and models Neuron 39 889 909 1:CAS:528:DC%2BD3sXnsFait7o%3D 10.1016/S0896-6273(03)00568-3 12971891 (Pubitemid 37130207)
3. AE Kingsbury CD Mardsen OJ Foster 1998 DNA fragmentation in human substantia nigra: apoptosis or perimortem effect? Mov Disord 13 877 884 1:STN:280:DyaK1M%2FktleisA%3D%3D 10.1002/mds.870130604 9827610
4. H Mochizuki K Goto H Mori Y Mizuno 1996 Histochemical detection of apoptosis in Parkinson's disease J Neurol Sci 137 120 123 1:STN:280: DyaK28znsFyktA%3D%3D 10.1016/0022-510X(95)00336-Z 8782165 (Pubitemid 26172041)
5. NA Tatton A Maclean-Fraser WG Tatton DP Perl CW Olanow 1998 A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease Ann Neurol 44 S142 S148 1:CAS:528:DyaK1cXmtFGkt7c%3D 9749586
6. MM Tompkins EJ Basgall E Zamrini WD Hill 1997 Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons Am J Pathol 150 119 131 1:STN:280:DyaK2s7lvV2rug%3D%3D 9006329
7. MS Saporito BA Thomas RW Scott 2000 MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo J Neurochem 75 1200 1208 1:CAS:528:DC%2BD3cXmtFyrsL0%3D 10.1046/j.1471-4159.2000.0751200.x 10936203 (Pubitemid 30660510)
8. P Hantraye M Varastet M Peschanski, et al. 1993 Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons Neuroscience 53 169 178 1:CAS:528:DyaK3sXksVKktLs%3D 10.1016/0306-4522(93)90295-Q 8469305 (Pubitemid 23083318)
9. NA Tatton SJ Kish 1997 In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining Neuroscience 77 1037 1048 1:CAS:528:DyaK2sXisVKrsLo%3D 10.1016/S0306-4522(96)00545-3 9130785 (Pubitemid 27128779)
10. A Hartley JM Stone C Heron JM Cooper AH Schapira 1994 Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease J Neurochem 63 1987 1990 1:CAS:528:DyaK2cXmsFaqtLg%3D 10.1046/j.1471-4159.1994.63051987.x 7931358
11. CP Fall JP Bennett Jr 1999 Characterization and time course of MPP+-induced apoptosis in human SH-SY5Y neuroblastoma cells J Neurosci Res 55 620 628 1:CAS:528:DyaK1MXhsFOktbg%3D 10.1002/(SICI)1097-4547(19990301)55: 5<620::AID-JNR9>3.0.CO;2-S 10082084 (Pubitemid 29117620)
12. G Vardatsikos A Sahu AK Srivastava 2009 The insulin-like growth factor family: molecular mechanisms, redox regulation, and clinical implications Antioxid Redox Signal 11 1165 1190 1:CAS:528:DC%2BD1MXkt1Chsb4%3D 10.1089/ars.2008.2161 19014342
13. R Kooijman 2006 Regulation of apoptosis by insulin-like growth factor (IGF)-I Cytokine Growth Factor Rev 17 305 323 1:CAS:528:DC%2BD28XntFSgsbk%3D 10.1016/j.cytogfr.2006.02.002 16621671 (Pubitemid 44038612)
14. J De Keyser N Wilczak JP De Backer L Herroelen G Vauquelin 1994 Insulin-like growth factor-I receptors in human brain and pituitary gland: an autoradiographic study Synapse 17 196 202 10.1002/syn.890170309 7974203 (Pubitemid 24204346)
15. A Nadjar O Berton S Guo, et al. 2009 IGF-1 signaling reduces neuro-inflammatory response and sensitivity of neurons to MPTP Neurobiol Aging 30 2021 2030 1:CAS:528:DC%2BD1MXht1yjtbzJ 10.1016/j.neurobiolaging.2008.02.009 18394756
16. T Kawano K Fukunaga Y Takeuchi, et al. 2001 Neuroprotective effect of sodium orthovanadate on delayed neuronal death after transient forebrain ischemia in gerbil hippocampus J Cereb Blood Flow Metab 21 1268 1280 1:CAS:528:DC%2BD3MXpt1Wktbc%3D 10.1097/00004647-200111000-00003 11702042
17. BH Poe C Linville DR Riddle WE Sonntag JK Brunso-Bechtold 2001 Effects of age and insulin-like growth factor-1 on neuron and synapse numbers in area CA3 of hippocampus Neuroscience 107 231 238 1:CAS:528:DC%2BD3MXos1Wru7g%3D 10.1016/S0306-4522(01)00341-4 11731097 (Pubitemid 33145345)
18. D Offen B Shtaif D Hadad A Weizman E Melamed I Gil-Ad 2001 Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson's disease Neurosci Lett 316 129 132 1:CAS:528:DC%2BD3MXovF2itLY%3D 10.1016/S0304-3940(01)02344-8 11744219 (Pubitemid 34020746)
19. MM Bilak RW Kuncl 2001 Delayed application of IGF-I and GDNF can rescue already injured postnatal motor neurons Neuroreport 12 2531 2535 1:CAS:528:DC%2BD3MXmtVOlsbY%3D 10.1097/00001756-200108080-00048 11496143
20. AM Vincent BC Mobley A Hiller EL Feldman 2004 IGF-I prevents glutamate-induced motor neuron programmed cell death Neurobiol Dis 16 407 416 1:CAS:528:DC%2BD2cXkvVegt7s%3D 10.1016/j.nbd.2004.03.001 15193297 (Pubitemid 38765100)
21. M Yamada K Tanabe K Wada, et al. 2001 Differences in survival-promoting effects and intracellular signaling properties of BDNF and IGF-1 in cultured cerebral cortical neurons J Neurochem 78 940 951 1:CAS:528:DC%2BD3MXms12kurk%3D 10.1046/j.1471-4159.2001.00497.x 11553668 (Pubitemid 32823143)
22. RA Ross BA Spengler JL Biedler 1983 Coordinate morphological and biochemical interconversion of human neuroblastoma cells J Natl Cancer Inst 71 741 747 1:CAS:528:DyaL3sXmtFSltro%3D 6137586
23. Y Wu Y Shang S Sun H Liang R Liu 2007 Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3beta/caspase-3 mediated signaling pathway Apoptosis 12 1365 1375 1:CAS:528:DC%2BD2sXmvVyqu74%3D 10.1007/s10495-007-0065-9 17508273 (Pubitemid 46988273)
24. Yang HJ, Wang L, Xia YY, Chang PN, Feng ZW (2009) NF-kappaB mediates MPP+-induced apoptotic cell death in neuroblastoma cells SH-EP1 through JNK and c-Jun/AP-1. Neurochem Int 56:128-134
25. Z Feng L Li PY Ng AG Porter 2002 Neuronal differentiation and protection from nitric oxide-induced apoptosis require c-Jun-dependent expression of NCAM140 Mol Cell Biol 22 5357 5366 1:CAS:528:DC%2BD38XltlGnsbY%3D 10.1128/MCB.22.15.5357-5366.2002 12101231 (Pubitemid 34755748)
26. RC Dodel Y Du KR Bales ZD Ling PM Carvey SM Paul 1998 Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons Neuroscience 86 701 707 1:CAS:528:DyaK1cXksVWlurc%3D 10.1016/S0306-4522(98)00154-7 9692710 (Pubitemid 28298729)
27. Y Du RC Dodel KR Bales R Jemmerson E Hamilton-Byrd SM Paul 1997 Involvement of a caspase-3-like cysteine protease in 1-methyl-4- phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons J Neurochem 69 1382 1388 1:CAS:528:DyaK2sXmsVCks78%3D 10.1046/j.1471-4159.1997. 69041382.x 9326266 (Pubitemid 27406938)
28. DA Cross DR Alessi P Cohen M Andjelkovich BA Hemmings 1995 Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378 785 789 1:CAS:528:DyaK28XltFWj 10.1038/378785a0 8524413 (Pubitemid 26004411)
29. T Kihira A Suzuki T Kondo, et al. 2009 Immunohistochemical expression of IGF-I and GSK in the spinal cord of Kii and Guamanian ALS patients Neuropathology 29 548 558 10.1111/j.1440-1789.2009.01010.x 19323791
30. M Pap GM Cooper 1998 Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway J Biol Chem 273 19929 19932 1:CAS:528:DyaK1cXlsVWgsrg%3D 10.1074/jbc.273.32.19929 9685326 (Pubitemid 28377539)
31. PC Chin N Majdzadeh SR D'Mello 2005 Inhibition of GSK3beta is a common event in neuroprotection by different survival factors Brain Res Mol Brain Res 137 193 201 1:CAS:528:DC%2BD2MXltFars7s%3D 10.1016/j.molbrainres.2005.03.004 15950778 (Pubitemid 40798902)
32. V Galvan A Logvinova S Sperandio H Ichijo DE Bredesen 2003 Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1) J Biol Chem 278 13325 13332 1:CAS:528:DC%2BD3sXislGru7g%3D 10.1074/jbc.M211398200 12556535 (Pubitemid 36800104)
33. R Aikin D Maysinger L Rosenberg 2004 Cross-talk between phosphatidylinositol 3-kinase/AKT and c-jun NH2-terminal kinase mediates survival of isolated human islets Endocrinology 145 4522 4531 1:CAS:528:DC%2BD2cXnvFOqtL4%3D 10.1210/en.2004-0488 15242986 (Pubitemid 39281444)
34. RT Allen KD Krueger A Dhume DK Agrawal 2005 Sustained Akt/PKB activation and transient attenuation of c-jun N-terminal kinase in the inhibition of apoptosis by IGF-1 in vascular smooth muscle cells Apoptosis 10 525 535 1:CAS:528:DC%2BD2MXktl2rsb8%3D 10.1007/s10495-005-1882-3 15909115 (Pubitemid 40896659)
35. Y Lin Q Yang X Wang ZG Liu 2006 The essential role of the death domain kinase receptor-interacting protein in insulin growth factor-I-induced c-Jun N-terminal kinase activation J Biol Chem 281 23525 23532 1:CAS:528: DC%2BD28XotVCmtL0%3D 10.1074/jbc.M601487200 16793775 (Pubitemid 44274127)
36. JW Kim JE Lee MJ Kim EG Cho SG Cho EJ Choi 2003 Glycogen synthase kinase 3 beta is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1) J Biol Chem 278 13995 14001 1:CAS:528:DC%2BD3sXjtVSiurw%3D 10.1074/jbc.M300253200 12584189 (Pubitemid 36799943)
37. S Dore S Kar R Quirion 1997 Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity Proc Natl Acad Sci USA 94 4772 4777 1:CAS:528:DyaK2sXjtVylurY%3D 10.1073/pnas.94.9.4772 9114067 (Pubitemid 27194319)
38. CC Matthews EL Feldman 1996 Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death J Cell Physiol 166 323 331 1:CAS:528:DyaK28XotFelsA%3D%3D 10.1002/(SICI)1097- 4652(199602)166:2<323::AID-JCP10>3.0.CO;2-C 8591992 (Pubitemid 26042409)
39. Yuan Z, Kim D, Shu S, et al (2010) Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120. J Biol Chem 285:3815-3824
40. P Kenchappa A Yadav G Singh S Nandana K Banerjee 2004 Rescue of TNFalpha-inhibited neuronal cells by IGF-1 involves Akt and c-Jun N-terminal kinases J Neurosci Res 76 466 474 1:CAS:528:DC%2BD2cXjvVyjsbg%3D 10.1002/jnr.20081 15114618 (Pubitemid 38584574)
41. GM Leinninger C Backus MD Uhler SI Lentz EL Feldman 2004 Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons FASEB J 18 1544 1546 1:CAS:528:DC%2BD2cXotFGisbc%3D 15319368
42. EM Halvorsen J Dennis P Keeney TW Sturgill JB Tuttle JB Bennett Jr 2002 Methylpyridinium (MPP(+))- and nerve growth factor-induced changes in pro- and anti-apoptotic signaling pathways in SH-SY5Y neuroblastoma cells Brain Res 952 98 110 1:CAS:528:DC%2BD38XnsVSnsrk%3D 10.1016/S0006-8993(02)03216-X 12363409 (Pubitemid 35279492)
43. A Nitta WH Zheng R Quirion 2004 Insulin-like growth factor 1 prevents neuronal cell death induced by corticosterone through activation of the PI3K/Akt pathway J Neurosci Res 76 98 103 1:CAS:528:DC%2BD2cXjt1egtb4%3D 10.1002/jnr.20057 15048933 (Pubitemid 38445567)
44. RD Almeida BJ Manadas CV Melo, et al. 2005 Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways Cell Death Differ 12 1329 1343 1:CAS:528:DC%2BD2MXpvFCjur8%3D 10.1038/sj.cdd.4401662 15905876 (Pubitemid 41486103)
45. V Levresse L Butterfield E Zentrich LE Heasley 2000 Akt negatively regulates the cJun N-terminal kinase pathway in PC12 cells J Neurosci Res 62 799 808 1:CAS:528:DC%2BD3MXhvVKksLo%3D 10.1002/1097-4547(20001215)62:6<799::AID- JNR6>3.0.CO;2-1 11107164
46. BD Manning LC Cantley 2007 AKT/PKB signaling: navigating downstream Cell 129 1261 1274 1:CAS:528:DC%2BD2sXotV2hs7g%3D 10.1016/j.cell.2007.06.009 17604717 (Pubitemid 46962095)
47. D Allard N Figg MR Bennett TD Littlewood 2008 Akt regulates the survival of vascular smooth muscle cells via inhibition of FoxO3a and GSK3 J Biol Chem 283 19739 19747 1:CAS:528:DC%2BD1cXotF2kt7s%3D 10.1074/jbc.M710098200 18458087
48. TD King GN Bijur RS Jope 2001 Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium Brain Res 919 106 114 1:CAS:528:DC%2BD3MXnvFCksbY%3D 10.1016/S0006-8993(01)03005-0 11689167 (Pubitemid 33016593)
49. A Petit-Paitel F Brau J Cazareth J Chabry 2009 Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neurons PLoS One 4 e5491 10.1371/journal.pone.0005491 19430525
50. W Wang Y Yang C Ying, et al. 2007 Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity Neuropharmacology 52 1678 1684 1:CAS:528:DC%2BD2sXmtVegs70%3D 10.1016/j.neuropharm.2007.03.017 17517424 (Pubitemid 46843143)
51. Sun X, Huang L, Zhang M, Sun S, Wu Y (2010) Insulin like growth factor-1 prevents 1-mentyl-4-phenylphyridinium-induced apoptosis in PC12 cells through activation of glycogen synthase kinase-3beta. Toxicology 271:5-12
52. MB Youdim Z Arraf 2004 Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax Neuropharmacology 46 1130 1140 1:CAS:528:DC%2BD2cXjsVWgsLk%3D 10.1016/j.neuropharm.2004.02.005 15111020 (Pubitemid 38529937)
53. S Hunot M Vila P Teismann, et al. 2004 JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease Proc Natl Acad Sci USA 101 665 670 1:CAS:528: DC%2BD2cXmsFGltg%3D%3D 10.1073/pnas.0307453101 14704277 (Pubitemid 38084694)
54. H Jiang Y Ren J Zhao J Feng 2004 Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis Hum Mol Genet 13 1745 1754 1:CAS:528:DC%2BD2cXlvFGqsbw%3D 10.1093/hmg/ddh180 15198987 (Pubitemid 39173443)
55. XG Xia T Harding M Weller A Bieneman JB Uney JB Schulz 2001 Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease Proc Natl Acad Sci USA 98 10433 10438 1:CAS:528:DC%2BD3MXmvFWhsrk%3D 10.1073/pnas.181182298 11504916 (Pubitemid 32803037)
56. AC Maroney JP Finn D Bozyczko-Coyne, et al. 1999 CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults J Neurochem 73 1901 1912 1:CAS:528:DyaK1MXntVWisLk%3D 10537048
57. W Wang C Ma Z Mao M Li 2004 JNK inhibition as a potential strategy in treating Parkinson's disease Drug News Perspect 17 646 654 1:CAS:528: DC%2BD2MXjt12lsb4%3D 10.1358/dnp.2004.17.10.873916 15696229 (Pubitemid 40224050)
58. T Duka V Duka JN Joyce A Sidhu 2009 Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models FASEB J 23 2820 2830 1:CAS:528:DC%2BD1MXhtFagsrrE 10.1096/fj.08-120410 19369384
59. R Mishra MK Barthwal G Sondarva, et al. 2007 Glycogen synthase kinase-3beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3 J Biol Chem 282 30393 30405 1:CAS:528:DC%2BD2sXhtFGgsrjE 10.1074/jbc.M705895200 17711861 (Pubitemid 350035219)
60. A Bonni A Brunet AE West SR Datta MA Takasu ME Greenberg 1999 Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms Science 286 1358 1362 1:CAS:528:DyaK1MXnsVeku7s%3D 10.1126/science.286.5443.1358 10558990 (Pubitemid 29535895)
61. A Gozdz A Habas J Jaworski, et al. 2003 Role of N-methyl-D-aspartate receptors in the neuroprotective activation of extracellular signal-regulated kinase 1/2 by cisplatin J Biol Chem 278 43663 43671 1:CAS:528: DC%2BD3sXosFSrtr8%3D 10.1074/jbc.M301554200 12930843 (Pubitemid 37345993)
62. K Jin XO Mao Y Zhu DA Greenberg 2002 MEK and ERK protect hypoxic cortical neurons via phosphorylation of Bad J Neurochem 80 119 125 1:CAS:528: DC%2BD38Xjt1ajtA%3D%3D 10.1046/j.0022-3042.2001.00678.x 11796750 (Pubitemid 34614584)
63. M Stanciu Y Wang R Kentor, et al. 2000 Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures J Biol Chem 275 12200 12206 1:CAS:528:DC%2BD3cXisl2jtb4%3D 10.1074/jbc.275.16.12200 10766856 (Pubitemid 30237798)
64. T Satoh D Nakatsuka Y Watanabe I Nagata H Kikuchi S Namura 2000 Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons Neurosci Lett 288 163 166 1:CAS:528:DC%2BD3cXktlKru7s%3D 10.1016/S0304-3940(00) 01229-5 10876086 (Pubitemid 30392436)
65. E Runden PO Seglen FM Haug, et al. 1998 Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice cultures: evidence for a MAP kinase-dependent mechanism J Neurosci 18 7296 7305 1:CAS:528:DyaK1cXmt1SjtLg%3D 9736650